Melissa A. Moss - Publications

Biomedical Engineering University of South Carolina, Columbia, SC 
Biomedical Engineering

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Moore KA, Pate KM, Soto-Ortega DD, Lohse S, van der Munnik N, Lim M, Jackson KS, Lyles VD, Jones L, Glassgow N, Napumecheno VM, Mobley S, Uline MJ, Mahtab R, Murphy CJ, ... Moss MA, et al. Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation. Journal of Biological Engineering. 11: 5. PMID 28191036 DOI: 10.1186/s13036-017-0047-6  0.68
2016 Pate KM, Rogers M, Reed JW, van der Munnik N, Vance SZ, Moss MA. Anthoxanthin Polyphenols Attenuate Aβ Oligomer-induced Neuronal Responses Associated with Alzheimer's Disease. Cns Neuroscience & Therapeutics. PMID 27864869 DOI: 10.1111/cns.12659  0.68
2016 Dean DN, Pate KM, Moss MA, Rangachari V. Conformational Dynamics of Specific Aβ Oligomers Govern Their Ability to Replicate and Induce Neuronal Apoptosis. Biochemistry. PMID 27013020 DOI: 10.1021/acs.biochem.6b00161  1
2016 Ghag G, Wolf LM, Reed RG, Van Der Munnik NP, Mundoma C, Moss MA, Rangachari V. Fully reduced granulin-B is intrinsically disordered and displays concentration-dependent dynamics. Protein Engineering, Design & Selection : Peds. PMID 26957645 DOI: 10.1093/protein/gzw005  1
2015 Chakrabarti M, McDonald AJ, Will Reed J, Moss MA, Das BC, Ray SK. Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26682679 DOI: 10.3233/JAD-150450  1
2015 Johnson CM, Pate KM, Shen Y, Viswanath A, Tan R, Benicewicz BC, Moss MA, Greytak AB. A methacrylate-based polymeric imidazole ligand yields quantum dots with low cytotoxicity and low nonspecific binding. Journal of Colloid and Interface Science. 458: 310-4. PMID 26247382 DOI: 10.1016/j.jcis.2015.07.069  1
2014 Kumar A, Pate KM, Moss MA, Dean DN, Rangachari V. Self-propagative replication of Aβ oligomers suggests potential transmissibility in Alzheimer disease. Plos One. 9: e111492. PMID 25365422 DOI: 10.1371/journal.pone.0111492  1
2014 Pryor NE, Moss MA, Hestekin CN. Capillary electrophoresis for the analysis of the effect of sample preparation on early stages of Aβ1-40 aggregation. Electrophoresis. 35: 1814-20. PMID 24729203 DOI: 10.1002/elps.201400012  1
2014 Turner JP, Lutz-Rechtin T, Moore KA, Rogers L, Bhave O, Moss MA, Servoss SL. Rationally designed peptoids modulate aggregation of amyloid-beta 40. Acs Chemical Neuroscience. 5: 552-8. PMID 24689364 DOI: 10.1021/cn400221u  1
2013 Pate K, Rogers M, Moss MA. Ability of polyphenols to attenuate alzheimer's disease by reducing nuclear factor- ΚB activation through inhibition of both amyloid- Î' oligomer formation and reactive oxygen species Food, Pharmaceutical and Bioengineering Division 2013 - Core Programming Area At the 2013 Aiche Annual Meeting: Global Challenges For Engineering a Sustainable Future. 741.  1
2012 Pryor NE, Moss MA, Hestekin CN. Unraveling the early events of amyloid-β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size. International Journal of Molecular Sciences. 13: 3038-72. PMID 22489141 DOI: 10.3390/ijms13033038  1
2011 Pryor E, Kotarek JA, Moss MA, Hestekin CN. Monitoring insulin aggregation via capillary electrophoresis. International Journal of Molecular Sciences. 12: 9369-88. PMID 22272138 DOI: 10.3390/ijms12129369  1
2011 Soto-Ortega DD, Murphy BP, Gonzalez-Velasquez FJ, Wilson KA, Xie F, Wang Q, Moss MA. Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center. Bioorganic & Medicinal Chemistry. 19: 2596-602. PMID 21458277 DOI: 10.1016/j.bmc.2011.03.010  1
2011 Gonzalez-Velasquez F, Reed JW, Fuseler JW, Matherly EE, Kotarek JA, Soto-Ortega DD, Moss MA. Activation of brain endothelium by soluble aggregates of the amyloid-β protein involves nuclear factor-κB. Current Alzheimer Research. 8: 81-94. PMID 21143156 DOI: 10.2174/156720511794604606  1
2011 Zhang W, Gilstrap K, Wu L, Moss MA, He X, Wang Q, Lu X. Controlled release and intracellular delivery of small molecules using thermally responsive pluronic F127-chitosan nanocapsules Asme 2011 Summer Bioengineering Conference, Sbc 2011. 445-446. DOI: 10.1115/SBC2011-53517  1
2010 Zhang W, Gilstrap K, Wu L, K C RB, Moss MA, Wang Q, Lu X, He X. Synthesis and characterization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules. Acs Nano. 4: 6747-59. PMID 21038924 DOI: 10.1021/nn101617n  1
2010 Kotarek JA, Moss MA. Impact of phospholipid bilayer saturation on amyloid-beta protein aggregation intermediate growth: a quartz crystal microbalance analysis. Analytical Biochemistry. 399: 30-8. PMID 20018160 DOI: 10.1016/j.ab.2009.12.016  1
2010 Gonzalez-Velasquez FJ, Reed JW, Fuseler JW, Matherly EE, Kotarek JA, Soto-Ortega DD, Moss MA. Soluble amyloid-β protein aggregates induce nuclear factor-κB mediated upregulation of adhesion molecule expression to stimulate brain endothelium for monocyte adhesion Journal of Adhesion Science and Technology. 24: 2105-2126. DOI: 10.1163/016942410X507948  1
2009 Davis TJ, Soto-Ortega DD, Kotarek JA, Gonzalez-Velasquez FJ, Sivakumar K, Wu L, Wang Q, Moss MA. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight. Molecular Pharmacology. 76: 405-13. PMID 19483107 DOI: 10.1124/mol.109.055301  1
2009 Reyes Barcelo AA, Gonzalez-Velasquez FJ, Moss MA. Soluble aggregates of the amyloid-beta peptide are trapped by serum albumin to enhance amyloid-beta activation of endothelial cells. Journal of Biological Engineering. 3: 5. PMID 19397812 DOI: 10.1186/1754-1611-3-5  1
2008 Gonzalez-Velasquez FJ, Kotarek JA, Moss MA. Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers. Journal of Neurochemistry. 107: 466-77. PMID 18702666 DOI: 10.1111/j.1471-4159.2008.05618.x  1
2008 Kotarek JA, Johnson KC, Moss MA. Quartz crystal microbalance analysis of growth kinetics for aggregation intermediates of the amyloid-beta protein. Analytical Biochemistry. 378: 15-24. PMID 18396143 DOI: 10.1016/j.ab.2008.03.022  1
2008 Gonzalez-Velasquez FJ, Moss MA. Soluble aggregates of the amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells. Journal of Neurochemistry. 104: 500-13. PMID 17953673 DOI: 10.1111/j.1471-4159.2007.04988.x  1
2008 Kotarek JA, Johnson KC, Moss MA. Quartz crystal microbalance analysis of growth kinetics for aggregation intermediates of the amyloid-β protein Aiche Annual Meeting, Conference Proceedings 1
2008 Gonzalez-Velasquez FJ, Kotarek JA, Moss MA. Activation of endothelium in Alzheimer's disease brain involves soluble aggregates of the amyloid-beta protein Aiche Annual Meeting, Conference Proceedings 1
2005 Nichols MR, Moss MA, Reed DK, Hoh JH, Rosenberry TL. Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers. Microscopy Research and Technique. 67: 164-74. PMID 16103999 DOI: 10.1002/jemt.20189  1
2005 Nichols MR, Moss MA, Reed DK, Hoh JH, Rosenberry TL. Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers. Biochemistry. 44: 165-73. PMID 15628857 DOI: 10.1021/bi048846t  1
2005 Nichols MR, Moss MA, Reed DK, Cratic-McDaniel S, Hoh JH, Rosenberry TL. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. The Journal of Biological Chemistry. 280: 2471-80. PMID 15528204 DOI: 10.1074/jbc.M410553200  1
2005 Moss MA. Identification of inhibitory binding faces of β-amyloid fibril formation Aiche Annual Meeting, Conference Proceedings. 8164.  1
2004 Moss MA, Varvel NH, Nichols MR, Reed DK, Rosenberry TL. Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association. Molecular Pharmacology. 66: 592-600. PMID 15322251 DOI: 10.1124/mol.66.3.  1
2003 Moss MA, Nichols MR, Reed DK, Hoh JH, Rosenberry TL. The peptide KLVFF-K(6) promotes beta-amyloid(1-40) protofibril growth by association but does not alter protofibril effects on cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Molecular Pharmacology. 64: 1160-8. PMID 14573766 DOI: 10.1124/mol.64.5.1160  1
2002 Nichols MR, Moss MA, Reed DK, Lin WL, Mukhopadhyay R, Hoh JH, Rosenberry TL. Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry. 41: 6115-27. PMID 11994007 DOI: 10.1021/bi015985r  1
2000 Moss MA, Zimmer S, Anderson KW. Role of metastatic potential in the adhesion of human breast cancer cells to endothelial monolayers. Anticancer Research. 20: 1425-33. PMID 10928052  1
2000 Moss MA, Anderson KW. Adhesion of cancer cells to endothelial monolayers: A study of initial attachment versus firm adhesion Journal of Adhesion. 74: 19-40.  1
Show low-probability matches.